CSF2 and neoplasm: This strategy broadly involves isolating autologous peripheral blood mononuclear cells in vitro, expanding the population of DCs through the addition of co‐stimulating factors including granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and IL‐4, before incubating the mature DCs with autologous tumour lysate or with specific TAAs.113, 114, 115, 116